Charleston, WV – The West Virginia Drug Intervention Institute (WV DII) has launched an online naloxone training course. Anyone throughout West Virginia is invited to participate in the training. Upon
completion of this online course, participants will be mailed a training certificate and two doses of auto-
injector naloxone free of charge.
Naloxone, an overdose reversal medication, is available in West Virginia through a standing order issued
by the State Health Officer, Dr. Ayne Amjad, or through area pharmacies without a prescription.
Recently, new legislation expanded the ability for certain non-profits and community organizations to
distribute naloxone to the community under Dr. Amjad’s standing order.
“Naloxone is a life-saving drug that we must continue to offer our loved ones and community members who are suffering from substance abuse disorder. We appreciate WV DII’s efforts to expand education around this life-saving intervention, especially in light of the tragic increase in overdose deaths,” said Dr.
Matthew Christensen, Director of the West Virginia Office of Drug Control Policy. “Recovery happens
every day and, in many instances, naloxone makes that possible.”
“While online (Zoom) trainings and face-to-face trainings are held throughout the state, the WV DII
wanted to create an opportunity for West Virginians to get trained on proper naloxone use and overdose
response immediately by creating an on-demand online course that can be accessed anytime and from any
computer,” explained WV DII President, Dr. Susan Bissett.
West Virginia experienced a 45% increase in the number of overdose deaths in 2020. In fact, according to
a report released by the United States National Office of Drug Control Policy last month, more West
Virginians died of drug overdoses last year than in any previous year on record—an estimated 1,275
deaths in 2020.
Media inquiries can be directed to the Institute’s President, Dr. Susan Bissett at: email@example.com or
(304) 941-4182. To participate in the training visit: https://wvdii.thinkific.com/courses/naloxone-training.
The West Virginia Drug Intervention Institute (WV DII) is a 501(c)3 non-profit organization located in
Charleston. The Institute’s mission is to reduce deaths in West Virginia from opioid and drug abuse by being (a) an independent advocate for life-enhancing drug policies, and practices, (b) a hub for coordinating drug response activities, and (c) an educational center to address the prevalence of drug abuse and the stigma of drug addiction.
SAMHSA is accepting applications for the National Training and Technical Assistance Center for Certified Community Behavioral Health Clinics‑Expansion Grants (TTA-CCBHC). The purpose of this program is to provide training and technical assistance to active SAMHSA CCBHC Expansion (CCBHC-E) grants in the following domains:
The TTA-CCBHC will ensure that CCBHC-E grantees are effective and successful in providing comprehensive 24/7 access to community‑based mental and substance use disorder services; treatment of co-occurring disorders; and physical healthcare in one single location. The TTA-CCBHC will also provide guidance to CCBHC-E grantees to promote adherence to the CCBHC model, certification, sustainability, and the implementation of processes that support access to care and evidence-based practices.
SAMHSA plans to issue 1 award of up to $3,000,000 per year for up to 5 years.
SAMHSA has published an update of Technical Assistance Publication (TAP) 34, Disaster Planning Handbook for Behavioral Health Service Programs, making available another tool to help support the response to COVID-19. The updated TAP provides guidance for developing or refreshing a comprehensive disaster plan. Topics include continuity planning, management of prescription medications, pandemic disease (including COVID-19), and testing and using the plan. The TAP also features worksheets to help guide program leaders through the disaster planning process.
Addiction Policy Forum invites you to a webinar with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), and Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), about the intersection of the disease of addiction and the COVID-19 pandemic. Topics covered will include the impact on people with substance use disorders, the latest on vaccinations, and the unique challenges that the pandemic has presented for people in recovery.
The West Virginia Department of Health and Human Resources’ Bureau for Behavioral Health (BBH) has released the following announcement of funding availability (AFA):
AFA 03-2021 Behavioral Health Workforce and Disparities Training Center(s)
The documents required for response to this AFA can be found here.
|Date of Release:||December 14, 2020|
|Technical Assistance:||Submit written requests to firstname.lastname@example.org|
|Application Deadline:||January 21, 2021|
|Funding Announcement(s) To Be Made:||To be posted on BBH Website|
|Funding Amount Available:||$425,000|
|Target Area to be Served||Statewide|
For technical assistance request, please include AFA 03-2021 in the subject line and forward inquiries via email to: email@example.com